Prana Thoracic raises $3 million to advance its lung tissue excision tool for lung cancer

Medical and Pharma Insider
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
-
MedNews on financings, strategic relationships, products, services and technology, including launches
-
MedTalks videos featuring conversations with management of companies with business or financial objectives
.jpg)
Pharma, Biopharma & Biotech News




- Mar 2
Mitsubishi Tanabe Pharma America announces preliminary results from Phase 3 ALS Trial

- Feb 24
Transcend Therapeutics, a mental health-focused biotechnology company, closes on $40 million


- Feb 22
Rare and orphan disease focused Quoin Pharmaceuticals (Nasdaq: QNRX) prices $7 million placement

- Feb 17
LifeArc Ventures participates in a $16 million financing for Maxion Therapeutics for antibody drugs

- Feb 15
Great Product Ventures initiates strategic relationship with life sciences regulatory services firm


- Feb 14
Nasdaq-listed SeqLL prices $1.8 million offering


- Feb 13
Quotient Sciences expands its early-phase formulation development capabilities for oral dosage forms


- Feb 1
Panbela prices $15 million public offering


- Jan 18
To address patient demand, SFJ Pharmaceuticals closes the acquisition of Bentracimab


- Jan 10
Trinity Biotech partners with imaware to deliver diagnostic testing solutions for digital health

- Jan 7
Retinal Degeneration Fund participates in a $78 million funding round for Perceive Biotherapeutics


- Jan 4
Apnimed Closes $79.75 Million for Phase 3 Trials of an Oral Medication for Obstructive Sleep Apnea


- Jan 3
Biocytogen and Hansoh Pharma Enter Into An Antibody License Agreement

- Dec 27, 2022
Ablaze Pharmaceuticals and Yonghe Pharma to develop targeted radiopharma therapies


- Dec 11, 2022
iBio, an AI-driven innovator of precision antibody immunotherapies, closes $3.5 million financing


- Dec 9, 2022
OMNY Health Closes $17 Million to Lead the Next Generation of Real-World Data-Driven Decision-Making


- Nov 29, 2022
MIT: New CRISPR-based tool inserts large DNA sequences at desired sites in cells


- Nov 23, 2022
scPharmaceuticals Announces Pricing of $50 Million Public Offering


- Nov 5, 2022
H.I.G. Capital acquires leading global clinical research organization Celerion


- Nov 2, 2022
J.P. Morgan Launches New Life Sciences Private Capital Team to Invest in Healthcare Companies


- Oct 28, 2022
Biotech Fund launched with $100 Million of Assets to Focus on Better Drugs, Devices and Diagnostics

- Oct 24, 2022
Biotechs, Developing Countries, Vaccine Manufacturers and Pharma Unite for Better Vaccine Access


- Oct 15, 2022
Integrated Drug Development Solution Company Altasciences Expands Support for Early Drug Development


- Oct 8, 2022
RadioMedix raises $40 million to advance its alpha therapy platform for oncology


- Oct 4, 2022
Eagle Pharmaceuticals and Enalare Therapeutics receive FDA Orphan Drug designation


- Oct 2, 2022
CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus

- Sep 28, 2022
Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome

- Sep 27, 2022
SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects


- Sep 3, 2022
Early-stage novel cell therapy company Neukio Biotherapeutics closes a $50 million financing


- Sep 1, 2022
OKYO plans fourth quarter IND filing for drug candidate to treat dry eye disease


- Aug 20, 2022
Laos-based pharmaceutical company BioSpring completes phase 1 of manufacturing facility


- Aug 13, 2022
Clario invests in new technology to reduce translation times for clinical trials


- Aug 5, 2022
Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy

- Aug 3, 2022
IDRx raises $122 million to transform cancer treatment with precision combination therapies


- Jul 30, 2022
Ozette closes on $26 million to advance its AI-Powered Single-Cell Immune Discovery Technology

- Jul 27, 2022
PCI Pharma Services to expand it’s UK manufacturing capability for manufacturing oncology treatments


- Jul 15, 2022
Manifold Bio Raises $40 Million for its next-generation protein engineering platform


- Jul 9, 2022
Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology


- Jul 5, 2022
Mindset Pharma develops an intranasal platform for psychedelic medicines


- Jul 1, 2022
Twist Bioscience and Ildong Pharmaceutical Collaborate on Antibody Discovery for Immuno-oncology


- Jun 24, 2022
Eton Pharmaceuticals sells its hospital products to Dr. Reddy’s Laboratories for $50 million


- Jun 23, 2022
A2W Pharma and MedC Biopharma Partner to develop Cannabinoid Therapeutics


- Jun 12, 2022
Degron Therapeutics Raises $22 Million for its Molecular-Glue-Based Targeted Protein Degradation


- Jun 8, 2022
L7 Informatics Raises $38 Million to Accelerate Innovation in Precision Healthcare


- Jun 7, 2022
OriCiro Closes on Financing to Advance Cell-Free Cloning technology for Large Circular DNA


- Jun 5, 2022
Imaging Endpoints and ImaginAb partner to supply doses of the CD8 imaging agent for clinical trials


- Jun 4, 2022
GE Healthcare will help advance cancer care and advance the practice of precision medicine


- May 29, 2022
KDx Diagnostics and UroGPO partner to offer the URO17 non-invasive urine test for bladder cancer


- May 27, 2022
Parallel Learning closes on $20 million to test, diagnose and empower special needs students
